- Home
- ATER vs AIMD Comparison
ATER vs AIMD Comparison
Compare ATER & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATER
- AIMD
- Stock Information
- Founded
- ATER 2014
- AIMD 1984
- Country
- ATER United States
- AIMD United States
- Employees
- ATER N/A
- AIMD N/A
- Industry
- ATER Home Furnishings
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- ATER Consumer Discretionary
- AIMD Health Care
- Exchange
- ATER Nasdaq
- AIMD Nasdaq
- Market Cap
- ATER 10.4M
- AIMD 16.9M
- IPO Year
- ATER N/A
- AIMD N/A
- Fundamental
- Price
- ATER $0.98
- AIMD $3.51
- Analyst Decision
- ATER
- AIMD
- Analyst Count
- ATER 0
- AIMD 0
- Target Price
- ATER N/A
- AIMD N/A
- AVG Volume (30 Days)
- ATER 121.7K
- AIMD 173.2K
- Earning Date
- ATER 08-13-2025
- AIMD 11-05-2025
- Dividend Yield
- ATER N/A
- AIMD N/A
- EPS Growth
- ATER N/A
- AIMD N/A
- EPS
- ATER N/A
- AIMD N/A
- Revenue
- ATER $85,668,000.00
- AIMD $110,870.00
- Revenue This Year
- ATER N/A
- AIMD N/A
- Revenue Next Year
- ATER $7.48
- AIMD N/A
- P/E Ratio
- ATER N/A
- AIMD N/A
- Revenue Growth
- ATER N/A
- AIMD 70.25
- 52 Week Low
- ATER $0.90
- AIMD $2.00
- 52 Week High
- ATER $3.84
- AIMD $5.00
- Technical
- Relative Strength Index (RSI)
- ATER 36.18
- AIMD 51.80
- Support Level
- ATER $0.94
- AIMD $3.56
- Resistance Level
- ATER $1.07
- AIMD $3.81
- Average True Range (ATR)
- ATER 0.05
- AIMD 0.25
- MACD
- ATER 0.01
- AIMD -0.03
- Stochastic Oscillator
- ATER 33.41
- AIMD 25.27
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.